Lung Cancer

Review the most current news and learn about the latest clinical developments in lung cancer treatment. Cancer Nursing Today provides the latest insights and perspectives on lung cancer risk in never-smokers, opioid education for patients with lung cancer, and more. From advances in screening techniques to prognostic models, explore the evolution of lung cancer care.

How Long Should Patients Receive Immune Checkpoint Inhibitor Therapy? I-STOP Study Provides Insights in Advanced NSCLC
Immune checkpoint inhibitors “demonstrated effectiveness” beyond 24 months, with “low rates” of progressive disease in those who stopped treatment at 24 months in a real-world population of patients with advanced non-small cell lung cancer (NSCLC), according to results from the I-STOP study. Maria Gemelli of IRCCS MultiMedica presented results from the I-STOP study during the European Lung Cancer Congress 2024. I-STOP is an ongoing observational, retrospective study that includes 17 centers in Italy. ...
Advertisement

Latest News

Advertisement

Knowledge Hubs

Breast Cancer
Breast Cancer

Trending

Advertisement
Advertisement
Latest News